New heart device aims to quiet chest pain in Hard-to-Treat condition
NCT ID NCT06991322
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called the A-FLUX Coronary Sinus Reducer to see if it can safely improve chest pain or discomfort in people with coronary microvascular dysfunction (CMD), a condition where tiny heart vessels don't work properly. About 30 adults with persistent symptoms despite standard treatments will receive the device. The goal is to check if the device can be placed safely and help reduce symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY MICROVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Hospital Clínic Barcelona
RECRUITINGBarcelona, Spain
-
University Medical Center Utrecht
RECRUITINGUtrecht, 3584, Netherlands
-
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu
RECRUITINGWarsaw, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer match the gold standard for heart scans?
- New balloon trick may save heart muscle during heart attacks
- New imaging method could replace risky heart wire test
- Hidden heart risk: tiny vessel damage may explain some heart attacks
- Stem cell shot for stubborn chest pain? early trial cut short
- New hope for millions with unexplained chest pain: study targets tiny heart vessels